InvestorsHub Logo
icon url

anotherboat12

08/17/20 10:48 AM

#8177 RE: GMoney74 #8175

The ceo said in an interview that they had the entire rights. That means 100%. IF he plans to partner, that will change and he eluded to that it would change just by his wording.
icon url

Andy2018

08/17/20 10:53 AM

#8179 RE: GMoney74 #8175

Is that a question? 100% revenue goes to RLFTF. Aviptadil is the Only covid CURE in the world now. not like other junk covid stocks u play. Don’t risk to chase you can’t afford. $RLFTF
icon url

pnnymn

08/17/20 10:55 AM

#8180 RE: GMoney74 #8175

you should take it for what its worth. You have your answer the Relief owns 100%. There is no use speculating on how much Nuero's cut will degrade the value of the Relief stock.If they get paid a fee or a small per centage, or a larger cut,we really dont know and its hardly worth consideration. Nueros has its place in the Relief machine and they will be compensated for it.Thats all we can say.Relief will pay its expenses as it rises to the top.
icon url

JBInvesting

08/17/20 11:27 AM

#8201 RE: GMoney74 #8175

"We have an US development company, NeuroRx, that administers the clinical development program for our drug RLF-100. NeuroRx is handling the day to day operations from a clinical development perspective."

I think they are just contracted to help Relief Therapeutics and even if they were to get .10 in commission, at these levels (SP) this is still a good investment!